Hydroxyzine hydrochloride
Hydroxyzinum Bluefish belongs to a group of medicines called sedating antihistamines. It inhibits certain brain functions without causing addiction. It also blocks histamine, a substance found in body tissues. It is effective in anxiety and itching states.
Hydroxyzinum Bluefish is used to treat:
Before taking Hydroxyzinum Bluefish, discuss with your doctor or pharmacist:
Taking Hydroxyzinum Bluefish may be associated with an increased risk of heart rhythm disorders, which can be life-threatening. Therefore, you should tell your doctor about any heart problems and about taking any other medicines, including those available without a prescription.
If you experience heart symptoms such as rapid heartbeat (palpitations), breathing difficulties, loss of consciousness while taking Hydroxyzinum Bluefish, seek medical attention immediately. Hydroxyzine treatment should be discontinued.
A side effect of Hydroxyzinum Bluefish may be dry mouth. Therefore, it is essential to maintain good oral hygiene while taking Hydroxyzinum Bluefish.
If you are undergoing allergy tests, Hydroxyzinum Bluefish treatment should be discontinued at least 5 days before the tests. Consult your doctor for advice.
Caution should be exercised in elderly patients. The treatment duration should be as short as possible.
Hydroxyzinum Bluefish should not be used in children under 6 years of age, as they may have difficulty swallowing tablets.
This medicine should not be used in children under 12 months of age, as it has not been studied in this age group.
Younger children are more prone to central nervous system side effects, such as seizures.
Tell your doctor or pharmacist about all medicines you are taking, have recently taken, or might take, including those available without a prescription. This includes:
You should also tell your doctor if you are taking:
Avoid taking Hydroxyzinum Bluefish with alcohol, as this combination may enhance the effect of Hydroxyzinum Bluefish and increase the risk of side effects.
Pregnancy
Do not take Hydroxyzinum Bluefish if you are pregnant or think you may be pregnant. If you plan to have a baby, ask your doctor for advice.
Hydroxyzine, the active substance of Hydroxyzinum Bluefish, passes into the fetus. There is a risk of fetal harm.
In newborns of mothers who took Hydroxyzinum Bluefish in late pregnancy and/or during delivery, the following symptoms may occur immediately or a few hours after birth:
tremors, muscle stiffness, and/or weakness, breathing difficulties, and urinary retention (urinary hesitation/incontinence).
Breastfeeding
Do not take Hydroxyzinum Bluefish during breastfeeding.
If treatment with Hydroxyzinum Bluefish is necessary, breastfeeding should be discontinued.
Consult your doctor. Hydroxyzine passes into breast milk.
Hydroxyzinum Bluefish may impair your ability to drive and use machines.
The medicine may cause drowsiness, decreased attention, and reduced reaction ability. Do not drive or operate machinery if you experience any of these symptoms.
The tablets of Hydroxyzinum Bluefish contain lactose. If you have been diagnosed with intolerance to some sugars, consult your doctor before taking the medicine.
The medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means it is considered "sodium-free".
Always take this medicine exactly as your doctor or pharmacist has told you. If you are not sure, ask your doctor or pharmacist.
The dose is determined by your doctor, who will adjust it individually for you.
Hydroxyzinum Bluefish should be taken in the smallest effective dose, and the treatment duration should be as short as possible.
The 25 mg tablet can be divided into two equal doses.
Recommended dose:
Itching
Adults:
The initial dose is 25 mg in the evening, about an hour before bedtime.
If necessary, up to 25 mg can be taken 3 to 4 times a day. The maximum daily dose for adults is 100 mg.
Children over 6 years of age
1-2 mg/kg body weight per day, divided into several doses.
In children with a body weight over 40 kg, the maximum daily dose is 100 mg.
In children with a body weight up to 40 kg, the maximum daily dose is 2 mg/kg body weight per day.
Anxiety
Adults:
50 mg per day, divided into 3 doses: half a tablet (12.5 mg), half a tablet (12.5 mg), and 1 tablet (25 mg).
In severe cases, doses up to 100 mg per day can be taken. The maximum daily dose for adults is 100 mg.
In anxiety treatment, this medicine should only be used as supplementary treatment. Do not change the dose without consulting your doctor.
Due to the prolonged effect, it is recommended to start treatment with half the recommended dose in elderly patients. In elderly patients, the maximum daily dose is 50 mg.
In patients with moderate or severe renal impairment, the dose should be reduced.
In patients with reduced liver function, the daily dose should be reduced.
In adolescents and children over 6 years of age, Hydroxyzinum Bluefish is intended only for the treatment of itching.
If a child has difficulty swallowing tablets, other hydroxyzine-containing medicines may be more suitable. Consult your doctor.
Tablets should be swallowed with a sufficient amount of water. Tablets can be taken with or without food.
If you have taken more than the prescribed dose of Hydroxyzinum Bluefish, contact your doctor immediately, especially if it concerns a child. In case of overdose, symptomatic treatment can be applied. ECG monitoring is recommended due to the possibility of heart rhythm disorders, such as QT interval prolongation or torsades de pointes.
Do not take a double dose to make up for a forgotten tablet.
If you have any further questions about taking this medicine, ask your doctor or pharmacist.
Like all medicines, Hydroxyzinum Bluefish can cause side effects, although not everybody gets them.
Other possible side effects:
Very common side effects (may affect more than 1 in 10 people):
Common side effects (may affect up to 1 in 10 people):
Uncommon side effects (may affect up to 1 in 100 people):
Rare side effects (may affect up to 1 in 1,000 people):
Very rare side effects (may affect less than 1 in 10,000 people):
Frequency not known (frequency cannot be estimated from available data):
If you experience any side effects, including those not listed in this package leaflet, please inform your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety, Ministry of Health
Al. Jerozolimskie 181C
02-222 Warsaw
Tel.: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Blister:
No special precautions for storage temperature.
Bottle:
No special precautions for storage temperature.
Keep the bottle tightly closed to protect from moisture.
Do not use this medicine after the expiry date stated on the carton, blister, and bottle after "EXP". The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
10 mg tablets:White to almost white, 5.0 mm in diameter, round, biconvex, coated tablets.
25 mg tablets: White to almost white, oval, capsule-shaped, 10.0 mm x 4.0 mm, biconvex, coated tablets with a dividing line on both sides. The tablet can be divided into two equal doses.
10 mg tablets:
Blister, in a cardboard box:
10, 20, 25, 30, 50, 60, 84, 90, 100, and 250 tablets.
Bottle with child-resistant cap, in a cardboard box:
25, 30, 84, and 100 tablets. Also contains silica gel desiccant.
Bottle with cap, in a cardboard box:
250 tablets. Also contains silica gel desiccant.
Packaging for dispensing by medical personnel.
25 mg tablets:
Blister, in a cardboard box:
10, 20, 25, 28, 30, 50, 60, 90, 100, and 250 tablets.
Bottle with child-resistant cap, in a cardboard box:
20, 25, 28, 30, 50, 60, and 100 tablets. Also contains silica gel desiccant.
Bottle with cap, in a cardboard box:
250 tablets. Also contains silica gel desiccant.
Packaging for dispensing by medical personnel.
Not all pack sizes may be marketed.
Bluefish Pharmaceuticals AB
P.O. Box 49013
100 28 Stockholm
Sweden
tel. +46 8 51 91 16 00
Bluefish Pharmaceuticals AB
Gävlegatan 22
113 30 Stockholm
Sweden
Member State | Trade name |
Austria | Hydroxyzin Bluefish 10 mg/25 mg Filmtabletten |
Poland | Hydroxyzinum Bluefish |
Sweden | Hydroxyzine Bluefish AB |
Date of last revision of the package leaflet:06/2024
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.